EUVIMEDEUVIMED entdecken
Crossref

Long-Term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ as a Boosting Vaccine for BCG

Li-Rong Mao iD, Jian-Peng Du, Xiao-Chun Wang, Li-Fa Xu iD, Yan-Peng Zhang, Qi-Shan Sun, Zi-Lun Shi, Ying-Ru Xing, Yi-Xin Su, Sheng-Jian Wang, Jian Wang, Ji-Lei Ma und 1 weitere

ACS Infectious Diseases · 2023

DOI: 10.1021/acsinfecdis.2c00570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2023. Verfasst von Li-Rong Mao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Medicine, Anhui University of Science and Technology, Huainan 232001, China. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Mycobacterium bovis, Tuberculosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Scientific Research Foundation of Education Department of Anhui Province of China, Graduate Student Innovation Fund, University Natural Science Research Project of Anhui Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisMycobacterium bovisTuberculosisAnimalsMiceBCG VaccineLiposomesAntigens, BacterialMice, Inbred C57BLAdjuvants, ImmunologicImmunization, Secondary

Stichwörter der Autor:innen

DR2/DIMQadjuvantmemory T cellssubunit vaccinetuberculosis

Substanzen

BCG VaccineLiposomesAntigens, BacterialAdjuvants, Immunologic

Autor:innen und Institutionen

  • Department of Immunology, School of Medicine, Anhui University of Science and Technology, Huainan 232001, China.
  • Department of Pathogen Biology, School of Medicine, Anhui University of Science and Technology, Huainan 232001, China.
  • Department of Cosmetology, School of Medicine, Huainan Union University, Huainan 232038, China.
  • Department of Clinical Laboratory, Huainan Chaoyang Hospital, Huainan 232007, China.
  • Department of Clinical Laboratory, Affiliated Cancer Hospital, Anhui University of Science and Technology, Huainan 232035, China.
  • Department of Clinical Laboratory, Anhui Zhongke Gengjiu Hospital, Hefei 230000, China.

ORCID-Profile: Li-Rong Mao, Li-Fa Xu

Förderung

  • Scientific Research Foundation of Education Department of Anhui Province of China
  • Graduate Student Innovation Fund
  • University Natural Science Research Project of Anhui Province

Zitieren

APA

Mao, L. R., Du, J. P., Wang, X. C., Xu, L. F., Zhang, Y. P., Sun, Q. S., Shi, Z. L., Xing, Y. R., Su, Y. X., Wang, S. J., Wang, J., Ma, J. L., & Zhang, J. Y. (2023). Long-Term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ as a Boosting Vaccine for BCG. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.2c00570

Vancouver

Mao LR, Du JP, Wang XC, Xu LF, Zhang YP, Sun QS, et al. Long-Term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ as a Boosting Vaccine for BCG. ACS Infectious Diseases. 2023. doi:10.1021/acsinfecdis.2c00570

BibTeX
@article{Mao2023,
  author = {Mao, Li-Rong and Du, Jian-Peng and Wang, Xiao-Chun and Xu, Li-Fa and Zhang, Yan-Peng and Sun, Qi-Shan and Shi, Zi-Lun and Xing, Ying-Ru and Su, Yi-Xin and Wang, Sheng-Jian and Wang, Jian and Ma, Ji-Lei and Zhang, Jing-Yan},
  title = {Long-Term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ as a Boosting Vaccine for BCG},
  journal = {ACS Infectious Diseases},
  year = {2023},
  doi = {10.1021/acsinfecdis.2c00570}
}
Kostenlos starten →